In mice, Sirt2 deletion aggravates HFD-induced obesity, promotes glucose intolerance and insulin resistance, exacerbates hepatic steatosis, and increases lipid deposition via the ER stress pathway (160). Here, SIRT2 is linked to Hepatic steatosis.